Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 April 2022 | Story Leonie Bolleurs | Photo Supplied
WJ swart
Prof Wijnand Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

Plant health is important for the survival of our planet and all its living creatures. Now, imagine an instrument that contains a DNA chip from virtually every known plant pathogen, where one can simply snip off a piece of the infected plant material, slip it into the ‘plant disease tricorder’, and within seconds you have not only a diagnosis of the disease, but all the information about its control too.

According to Prof Wijnand Swart, Professor of Plant Pathology in the Department of Plant Sciences at the University of the Free State (UFS) and President of the Southern African Society for Plant Pathology (SASPP), this concept might be a bit far-fetched, but is a distinct possibility for the not-too-distant future. “Without a doubt …,” he believes.

He was recently a guest on a series of radio talks on plant health in South Africa, hosted by the National Science and Technology Forum (NSTF) in partnership with Plaas/Farm TV (YouTube broadcaster). His talk on the topic, Whither (or wither) Plant Pathology in the next 50 years, was specifically focused on understanding the latest research and dynamics of the discipline in a South African context.

In terms of this futuristic perspective, he says collaboration between plant pathologists and biomedical and aeronautical engineers, nanotechnologists, and computer scientists will aid the development of micro-sensory technologies for the detection of new plant diseases that are relevant to biosecurity, plant disease diagnostics, and epidemiological modelling.

In his discussion, Prof Swart referred to the work of Prof John Lucas, former Head of Plant Pathology and Microbiology at the Rothamsted Research Station in the United Kingdom, who believes that there are three key issues facing plant pathologists in the 21st century. These are the strengthening of food security while simultaneously safeguarding the health of associated ecosystems and reducing the dependency on natural resources; the creation of pest and disease control systems that are sustainable and not compromised by the evolution of pest and pathogen strains; and the development of suitable crop protection technologies.

Future technologies

Based on the work of Prof Lucas, Prof Swart states that future technologies in plant health will develop in five areas. In the first area, he says DNA-based technologies will greatly increase the speed, sensitivity, and accuracy of pest and pathogen detection and diagnosis.

Also key here, is the integration of nanomaterials into disease management strategies and diagnostics. He says in the past decade, the use of nanotechnology in phytopathology has grown exponentially. According to him, nanotechnology can increase productivity using nano-pesticides and nano-fertilisers, improve soil quality by means of nano-zeolites and hydrogels, stimulate plant growth using nanomaterials, and provide smart monitoring via nano-sensors and wireless communication devices.

Prof Swart says according to Prof Lucas, the second area in which plant health technologies will grow is plant defence and immunity. When induced, plant resistance primes plants to deal with a diversity of biotic and abiotic stresses. Prospects of inducing chemically modulated plant resistance via biological agents (such as engineered microbes), might result in low-cost seed treatments, thereby removing the need for expensive chemical spray regimes.

Technology development in plant health will also become more evident in genetic diversification. Prof Swart believes sequencing the genomes of major crop species and their wild relatives will expand the known gene pool and diversify genetic resources available to plant breeders.

According to him, a new era is beckoning, where the prospect of crop pharmacology based on signal molecules and their receptors will become a reality. It will be based on the development of novel chemistries designed to manipulate specific molecular targets, by either regulating host resistance or disabling the disease-causing processes of pathogens.

The fifth area in which plant health technologies will develop, is ecological approaches to disease control. He says by understanding the ecology of pathogens, our ability to exploit their natural enemies will improve. Ecological approaches to plant disease control will have a significant impact on the introduction of invasive pathogen species, while the effect of climate change will influence the emergence of new plant diseases and epidemics. He strongly believes that it is important to take a holistic approach to understanding how and why plant pathogenesis occurs if we are to manage diseases effectively.

Future challenges

The development of these new technologies is very important, as there are several challenges that plant pathology will face in the future. These include the increasing demand for food to support the growing global population; the decreasing production potential of agriculture due to competition for fertile land; the increased risk of plant disease epidemics resulting from agricultural intensification; the depletion of natural resources; and the influence of climate change on interactions between plants and their pests or pathogens.

Prof Swart believes a ‘systems level understanding’ of phytobiomes (consisting of plants, their environment, and all their associated organisms) will enable us to produce sufficient crops to meet global demands while minimising negative impacts on our environment.

He concludes, saying that plant pathology will evolve as an interdisciplinary science. He adds that future research will focus on new problems that are traditionally seen as outside the core discipline of plant pathology. Furthermore, food security will be a dominant and important driver of plant pathology research, while the impact of climate change on plant diseases will be very significant. Finally, that the adaptive potential of plant and pathogen populations will be one of the most important predictors of the magnitude of climate change effects.

LISTEN: radio interview


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept